Comparison of long-term immunogenicity (23 years) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children. (Q36552883)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Comparison of long-term immunogenicity (23 years) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Qian Wu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Gui-hua Zhuang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Xue-liang Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Tie-jun Hou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Xiao-li Wei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Li-rong Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Min Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

Human Vaccines & Immunotherapeutics

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1071-1076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis.

9 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551878

The global impact of vaccination against hepatitis B: a historical overview

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551878

The natural history of chronic hepatitis B.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551878

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551878

Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551878

Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551878

Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551878

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

28 June 2018

1 reference

Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.

21 January 2018

1 reference

Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.

21 January 2018

1 reference

Long-term protection against carriage of hepatitis B virus after infant vaccination.

21 January 2018

1 reference

Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine

21 January 2018

1 reference

Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

21 January 2018

1 reference

Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.

21 January 2018

1 reference

[Efficacy and immune memory of plasma-derived hepatitis B vaccine 11 years after primary immunization]

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3551878

Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report

21 September 2018

1 reference

Recombinant versus plasma-derived hepatitis B vaccine: comparison of immunogenicity in medical students

21 January 2018

1 reference

12 December 2020

Evaluation of long-term efficacy on plasma-derived hepatitis B vaccine

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children

1 reference

12 December 2020

Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose

1 reference

12 December 2020

Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children

1 reference

12 December 2020

Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.20656

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22854666%20AND%20SRC:MED&resulttype=core&format=json